ABBV Insider Trading Activity and SEC Form 4 Filings
Trump's trades in ABBV
From his financial disclosures
$364K+
14 purchases
$269K+
8 sales
Purchase
Jul 31, 2026
Reported 53d later
$50K - $100K
Purchase
Jul 23, 2026
Reported 61d later
$50K - $100K
Purchase
Jun 23, 2026
Reported 60d later
$1K - $15K
Purchase
Jun 16, 2026
Reported 67d later
$50K - $100K
Sale
May 18, 2026
Reported 44d later
$100K - $250K
Sale
May 18, 2026
Reported 44d later
$1K - $15K
Includes 2 trades in ABBV bonds. Many orders in these accounts are placed by the account manager. See all 24 trades
ABBV insider trading summary
Over the past 12 months, insiders at AbbVie Inc. (ABBV) reported 5 sales worth $10.7M by 2 insiders and no open-market purchases on SEC Form 4. Net insider selling was $10.7M.
Latest ABBV insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 4, 2026 | David Ryan Purdue | SVP, Controller | Sell | $1.2M (5,230 @ $233.56) |
| Mar 2, 2026 | Perry C Siatis | EVP, GC and Secretary | Sell | $1.3M (5,777 @ $233.51) |
| Mar 2, 2026 | Perry C Siatis | EVP, GC and Secretary | Sell | $2.4M (10,291 @ $234.66) |
| Mar 2, 2026 | Perry C Siatis | EVP, GC and Secretary | Sell | $612K (2,600 @ $235.26) |
| Feb 25, 2026 | Perry C Siatis | EVP, GC and Secretary | Sell | $5.1M (22,381 @ $230.00) |
| Aug 12, 2025 | Azita Saleki-Gerhardt | EVP, Chief Operations Officer | Sell | $8.4M (42,370 @ $198.42) |
| Aug 5, 2025 | Nicholas Donoghoe | EVP, Chief Bus/Strat Officer | Sell | $641K (3,234.17 @ $198.27) |
| Aug 5, 2025 | Nicholas Donoghoe | EVP, Chief Bus/Strat Officer | Sell | $2.0M (10,061 @ $198.59) |
| Mar 31, 2025 | Jeffrey Ryan Stewart | EVP, Chief Commercial Officer | Sell | $5.4M (25,700 @ $209.49) |
| Mar 31, 2025 | Jeffrey Ryan Stewart | EVP, Chief Commercial Officer | Sell | $7.0M (33,132 @ $210.54) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.